FCGR3A and neoplasm: We confirm and extend this finding here: CD16a+ cell infiltration predicts longer OS for patients with HGSC, even after controlling for other significant variables, including tumor stage where CD16a cell density is elevated in stage IV compared to stage III HGSC.